-+ 0.00%
-+ 0.00%
-+ 0.00%

WuXi Biologics makes Forbes China ESG 50 list for 2026

PUBT·09/16/2026 08:03:09
Listen to the news
WuXi Biologics makes Forbes China ESG 50 list for 2026
  • WuXi Biologics was named to the 2026 Forbes China ESG 50 list, cited for Green CRDMO execution and ESG digital innovation.
  • Forbes China highlighted an ESG data governance system spanning global operations, supporting quantified management and traceability.
  • Scope 1 and Scope 2 GHG emission intensity fell 30% versus 2020; water intensity dropped 32% versus 2019, beating a 30% target.
  • A Smart ESG platform was built to standardize ESG data collection, track indicators, support carbon inventory, resource use, waste management.
  • Green CRDMO tools cited include WuXiUI production technology, single-use manufacturing, digital dashboards for site-level performance monitoring.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Wuxi Biologics (Cayman) Inc. published the original content used to generate this news brief on September 16, 2026, and is solely responsible for the information contained therein.